EverPoint Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

EverPoint Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-475,000	Closed	-$3.85M	–	571
2015 Q4	$3.85M	Sell	475,000 -175,000	-27%	-$1.24M	0.08%	288
2015 Q3	$3.93M	Buy	650,000 +220,000	+51%	+$1.59M	0.1%	251
2015 Q2	$3.54M	Buy	+430,000	New	+$3.42M	0.06%	329

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EverPoint Asset Management's CCXI Position: Q1 2016 in Review

EverPoint Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2016, closing a stake of 475,000 shares — an estimated $3.85M sold.

EverPoint Asset Management first reported a position in CCXI in Q2 2015 and held it in 3 quarters. The position peaked at $3.93M in Q3 2015. 71 funds tracked by Wall St. Rank hold CCXI as of Q1 2016.

EverPoint Asset Management reported no remaining ChemoCentryx, Inc. position as of Q1 2016 after selling out during the quarter.
EverPoint Asset Management sold 475,000 ChemoCentryx, Inc. shares in Q1 2016, an estimated $3.85M.
EverPoint Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2015 and held it in 3 quarters.
EverPoint Asset Management's ChemoCentryx, Inc. position peaked at $3.93M in Q3 2015.
71 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2016.

Based on EverPoint Asset Management's 13F filing for Q1 2016, filed 16 May 2016.